While the battle for cheaper medication goes on, could a part of the answer lie in the delivery of the product? The analysis finds that millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration. Researchers from the University of Michigan Rogel Cancer Center may have found a way to make the system more efficient, thus more cost-effective.
